[Treatment of ocular mycosis].
D000196:Actinomycosis / Q000188:drug therapy; D000666:Amphotericin B / Q000008:administration & dosage*; D000818:Animals; D000935:Antifungal Agents / Q000627:therapeutic use; D001285:Atropine / Q000008:administration & dosage; D002825:Chorioretinitis / Q000188:drug therapy; D003231:Conjunctivitis / Q000188:drug therapy; D005128:Eye Diseases / Q000188:drug therapy*; D006358:Hot Temperature / Q000627:therapeutic use; D006801:Humans; D053685:Laser Therapy; D008028:Light Coagulation; D009181:Mycoses / Q000188:drug therapy* / Q000628:therapy; D010866:Natamycin / Q000008:administration & dosage; D009617:Nocardia Infections / Q000188:drug therapy; D009761:Nystatin / Q000008:administration & dosage*; D010406:Penicillins / Q000627:therapeutic use; D011817:Rabbits; D013174:Sporotrichosis / Q000188:drug therapy; D013307:Streptomycin / Q000008:administration & dosage; D013409:Sulfacetamide / Q000008:administration & dosage; D013411:Sulfadiazine / Q000008:administration & dosage; D014822:Vitreous Body
D000935:Antifungal Agents; D010406:Penicillins; D013411:Sulfadiazine; D009761:Nystatin; D013409:Sulfacetamide; D001285:Atropine; D000666:Amphotericin B; D010866:Natamycin; D013307:Streptomycin
Traitement des mycoses oculaires.